6
Clinical implications for MSI, MLH1 methylation analysis and IHC in Lynch screening for endometrial cancer patients: an analysis of 940 endometrioid endometrial cancer cases from the GOG0210 study
Saturday, March 28, 2015: 10:30 AM
International Ballroom (Hilton Chicago)
C. C. Billingsley1, D. E. Cohn1, D. G. Mutch2, R. Broaddus3, N. Ramirez4, H. Lankes5, S. Ali6, F. J. Backes7, L. M. Landrum8, P. J. Goodfellow1, M. A. Geller9, P. A. DiSilvestro10, M. L. Pearl11, S. B. Lele6, C. C. Pritchard12 and L. A. Brinton13
1The Ohio State University, Columbus, OH, 2Washington University School of Medicine, St. Louis, MO, 3The University of Texas MD Anderson Cancer Center, Houston, TX, 4Gynecologic Oncology Group Tissue Bank, Biopathology Center, Research Institute at Nationwide Children's Hospital, Columbus, OH, 5Gynecologic Oncology Group Statistical and Data Center, Buffalo, NY, 6Roswell Park Cancer Institute, Buffalo, NY, 7The Ohio State University, James Cancer Hospital, Columbus, OH, 8The University of Oklahoma, Oklahoma City, OK, 9University of Minnesota, Minneapolis, MN, 10Women and Infants Hospital, Brown University, Providence, RI, 11Stony Brook University Hospital, St. James, NY, United States, 12University of Washington, Seattle, WA, 13Brazilian National Cancer Institute, Rockville, MD
